secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOVIE INC. (BIVI)
CIK:        0001580149
Form:       8-K
Filed at:   2024-01-19T23:59:59+00:00
Accession:  0001520138-24-000034
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioVie files prospectus supplement for up to $25M ATM; already raised $59.4M from 8.1M shares
--------------------------------------------------------------------------------

- Filed prospectus supplement under new shelf registration (333-274083) for continued at-the-market sales of common stock.
- As of Jan 19, 2024, issued 8,136,058 shares under existing Sales Agreement with Cantor Fitzgerald for net proceeds of $59.4M.
- Commissions and expenses totaled ~$1.8M; new shelf effective Aug 28, 2023 replaces expiring Feb 2, 2024 shelf.
- Up to $25M aggregate offering price authorized under the new supplement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1580149/000152013824000034/0001520138-24-000034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1580149/000152013824000034/bivi-20240119_8k.htm
  HTML page:      https://secwatch.observer/filing/0001520138-24-000034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer